The Week In... Nursing + Healthcare (20-24/04)

COVID-19: Plasma blood treatment to be trialled, the NIHR and UKRI fund research into COVID-19 infection and immunity in children and teenagers, the RCN hits back at ‘unacceptable’ PPE guidance, and Novartis is to sponsor hydroxychloroquine trials in hospitalised COVID-19 patients.

The National Institute for Health Research and UK Research and Innovation (UKRI) are funding new research designed to determine rates of coronavirus infection and immunity in children and teenagers across the UK, to help further shape the response to the pandemic.